Market News Archive
Stay updated with the latest announcements
DSE NEWS: Greetings Message
Honorable Investors, Good morning! Please make your investment decision based on Company fundamentals, technical analysis, price level and disclosed information. Avoid rumor-based speculations.
DSE NEWS: Daily Turnover of Main Board
Today's (28.08.2024) Total Trades: 176,993; Volume: 256,083,784 and Turnover: Tk. 8,986.48 million.
DGIC: Declaration of share receipt by a Director
Mr. Tahrin Aman, a Director of the company, has expressed his intention to receive 1,60,000 shares of the company from his mother Ms. Tazneen Aman (a General Shareholder of the company), by way of gift, outside the trading system of the Exchange within next 30 working days with effect from August 20, 2024.
HAMI: Regarding continuation of trading of the company under "Z" category
This refers to their earlier news regarding Interim Dividend Disbursement on August 07, 2024. In this respect, the interim dividend declared by the company does not appear to be justified by the profits on the basis of 3rd quarter reviewed financial statements which falls under non-compliance of the clause 2 of Bangladesh Securities and Exchange Commission (BSEC) Directive No. BSEC/CMRRCD/2009-193/77 dated May 20, 2024. (cont.)
ORIONPHARM: Query Response
In response to the DSE query dated August 27, 2024, the company has informed that they do not have any undisclosed material decision/information relating to the company's operation/profitability that might have impact on price fall of shares of the company.
KARNAPHULI: Buy Declaration of a Corporate Director
Meghna Life Insurance Co. Ltd., a Corporate Director of the Company, has expressed its intention to buy 2,97,523 shares of the Company at prevailing market price (in the Public Market) through Dhaka Stock Exchange PLC. within next 30 working days.
TB20Y0833: Resumption after Record date
Trading of 20Y BGTB 29/08/2033 Government Securities will resume on 29.08.2024.
TB20Y0832: Resumption after Record date
Trading of 20Y BGTB 29/08/2032 Government Securities will resume on 29.08.2024.
TB20Y0232: Resumption after Record date
Trading of 20Y BGTB 29/02/2032 Government Securities will resume on 29.08.2024.
TB15Y0828: Resumption after Record date
Trading of 15Y BGTB 29/08/2028 Government Securities will resume on 29.08.2024.
TB20Y0827: Resumption after Record date
Trading of 20Y BGTB 29/08/2027 Government Securities will resume on 29.08.2024.
TB2Y0925: Record date for entitlement of coupon payment
Record date for entitlement of coupon payment of 02Y BGTB 07/09/2025 Government Securities is 05.09.2024.
FAREASTFIN: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 29.08.2024 to 02.09.2024 and trading of the shares will remain suspended on record date i.e., 03.09.2024.
ONEBANKPLC: Dividend Disbursement
The company has informed that it has credited the Bonus Shares to the respective shareholders' BO Accounts and it has also disbursed the Cash Dividend to the respective shareholders for the year ended December 31, 2023.
WALTONHIL: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on 04-Sep-2024 at 03:00 PM to consider, among others, audited financial statements of the Company for the year ended on 30-Jun-2024.
DSE NEWS: Fortnightly Pujibazar
The 300th Edition (August 01-15, 2024) of Fortnightly Pujibazar has been published. Investors and any other interested person may collect copies of the same from DSE Reception or DSE Sales Center at 9/F, Motijheel C/A, Dhaka-1000 or contact at Mob: 01755538482, Ph: 41040189 - 200 Ext - 1167.
DSE NEWS: Monthly Review
The Monthly Review - July 2024 has been published. Investors and any other interested persons may collect copies of the same from DSE Reception or DSE Sales Center at 9/F, Motijheel C/A, Dhaka-1000. Mob: 01755538482, Ph: 41040189 - 200 Ext - 1167.
BXPHARMA: Query Response
In response to the DSE query dated August 27, 2024, the company has informed that they do not have any undisclosed material decision/information relating to the company's operation/profitability that might have impact on price fall of shares of the company.
CLICL: Q2 Financials
(Q2 Un-audited): As per life revenue account of the company for the period ended June 30, 2024: Balance of Life Insurance Fund was BDT 602,306,366 as on June 30, 2024 as against BDT 511,280,555 as on June 30, 2023 resulting a net increase of BDT 91,025,811. Total revenue was BDT 802,682,464 during April-June 2024 as against BDT 715,591,377 during April-June 2023. (cont.)
SONALIPAPR: Q3 Financials
(Q3 Un-audited): EPS was Tk. (3.60) for January-March 2024 as against Tk. (0.75) (adjusted) for January-March 2023; EPS was Tk. 1.80 for July 2023-March 2024 as against Tk. 5.40 (adjusted) for July 2022-March 2023. NOCFPS was Tk. 14.03 for July 2023-March 2024 as against Tk. 4.05 for July 2022-March 2023. NAV per share was Tk. 162.74 as on March 31, 2024 and Tk. 164.94 as on June 30, 2023. (cont.)